To evaluate the therapeutic potential of eEF2K inhibition in PDAC and its role in tumorigenesis, we administered nanoliposomal (NL) particles carrying eEF2K siRNA or control siRNA to athymic nude mice bearing PANC-1 or MiaPaCa-2 tumor xenografts. This evidence concerns the gene EEF2K and neoplasm.